Influence of enzyme inducing antiepileptic drugs on the pharmacokinetics of levetiracetam in patients with epilepsy

Epilepsy Research

Volumn 94, Issue 1-2, 2011, Pages 117-120

  Freitas Lima, Priscila ^a   Alexandre, Veriano ^a   Pereira, Leonardo Regis Leira ^a,b   Feletti, Fausto ^b   Perucca, Emilio ^b,c   Sakamoto, Americo Ceiki ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF PAVIA   (Italy)

^c C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

Author keywords

Drug interaction; Enzyme induction; Epilepsy; Levetiracetam; Pharmacokinetics

Indexed keywords

CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; ETHOSUXIMIDE; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN;

ABSENCE OF SIDE EFFECTS; ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG COMPETITION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; DRUG URINE LEVEL; EPILEPSY; FEMALE; HUMAN; MALE; MAXIMUM PLASMA CONCENTRATION; MULTICENTER STUDY; PRIORITY JOURNAL; SINGLE DRUG DOSE; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; AREA UNDER CURVE; CASE-CONTROL STUDIES; ENZYME INDUCTION; EPILEPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; PIRACETAM; TIME FACTORS; YOUNG ADULT;

EID: 79952439180     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2011.01.007     Document Type: Article

References (15)

1. Alexandre V., Capovilla G., Fattore C., Franco V., Gambardella A., Guerrini R., La Briola F., Ladogana M., Rosati E., Specchio L.M., Striano S., Perucca E. Characteristics of a large population of patients with refractory epilepsy attending tertiary referral centers in Italy. Epilepsia 2010, 51:921-925. SOPHIE Study Group.
2. Contin M., Albani F., Riva R., Baruzzi A. Levetiracetam therapeutic monitoring in patients with epilepsy - effects of concomitant antiepileptic drugs. Ther. Drug Monit. 2004, 26:375-379.
3. Dahlin M.G., Wide K., Ohman I. Age and comedications influence levetiracetam pharmacokinetics in children. Pediatr. Neurol. 2010, 43:231-235.
4. Hirsch L.J., Arif H., Buchsbaum R., Weintraub D., Lee J., Chang J.T., Resor S.R., Bazil C.W. Effect of age and comedication on levetiracetam pharmacokinetics and tolerability. Epilepsia 2007, 48:1351-1359.
5. Isoherranen N., Spiegelstein O., Bialer M., Zhang J., Merriweather M., Yagen B., Roeder M., Triplett A.A., Schurig V., Finnell R.H. Developmental outcome of levetiracetam, its major metabolite in humans, 2-pyrrolidinone N-butyric acid, and its enantiomer (R)-alpha-ethyl-oxo-pyrrolidine acetamide in a mouse model of teratogenicity. Epilepsia 2003, 44:1280-1288.
6. Kaur S., Ali B. The effects of phenobarbital, 3-methylcholanthrene and benzo(a)pyrene on the hydrolysis of xenobiotics in the rat. Biochem. Pharmacol. 1983, 32:3479-3480.
7. May T.W., Rambeck B., Jürgens U. Serum concentrations of levetiracetam in epileptic patients: the influence of dose and co-medication. Ther. Drug Monit. 2003, 25:690-699.
8. Nousiainen U., Hänninen O. On the inducibility of cytosolic and microsomal carboxylesterase by phenobarbital in rat tissues. Acta Pharmacol. Toxicol. 1981, 49:77-80.
9. Patsalos P.N. Clinical pharmacokinetics of levetiracetam. Clin. Pharmacokinet. 2004, 43:707-724.
10. Perucca E., Gidal B.E., Baltes E. Effects of comedication on levetiracetam pharmacokinetics: a pooled analysis of data from randomized adjunctive therapy trials. Epilepsy Res. 2003, 53:47-56.
11. Ratnaraj N., Doheny H.C., Patsalos P.N. A micromethod for the determination of the new antiepileptic drug levetiracetam (ucb L059) in serum or plasma by high performance liquid chromatography. Ther. Drug Monit. 1996, 18:154-157.
12. Satoh T., Moroi K. Effect of pretreatment with tricresylphosphates and phenobarbital on the metabolism and toxicity of procaine in rats. Jpn. J. Pharmacol. 1977, 27:233-237.
13. Schwark W.S., Ecobichon D.J. Subcellular localization and drug-induced changes of rat liver and kidneys esterases. Can. J. Physiol. Pharmacol. 1968, 46:207-212.
14. 14C-levetiracetam, a new antiepileptic agent, in healthy volunteers. Eur. J. Clin. Pharmacol. 2003, 59:621-630.
15. Tybring G., von Bahr C., Bertilsson L., Collste H., Glaumann H., Solbrand M. Metabolism of carbamazepine and its epoxide metabolite in human and rat liver in vitro. Drug Metab. Dispos. 1981, 9:561-564.